265 related articles for article (PubMed ID: 9181357)
1. Genetics of type III hyperlipoproteinemia.
Feussner G; Piesch S; Dobmeyer J; Fischer C
Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
[TBL] [Abstract][Full Text] [Related]
2. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
Feussner G; Dobmeyer J; Nissen H; Hansen TS
Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III.
Utermann G; Vogelberg KH; Steinmetz A; Schoenborn W; Pruin N; Jaeschke M; Hees M; Canzler H
Clin Genet; 1979 Jan; 15(1):37-62. PubMed ID: 215360
[TBL] [Abstract][Full Text] [Related]
4. [Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes].
Borghini I; James RW; Pometta D
Schweiz Med Wochenschr; 1989 Dec; 119(50):1821-4. PubMed ID: 2609136
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.
Wardell MR; Brennan SO; Janus ED; Fraser R; Carrell RW
J Clin Invest; 1987 Aug; 80(2):483-90. PubMed ID: 3038959
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of type III hyperlipoproteinemia in Germany.
Feussner G; Feussner V; Hoffmann MM; Lohrmann J; Wieland H; März W
Hum Mutat; 1998; 11(6):417-23. PubMed ID: 9603433
[TBL] [Abstract][Full Text] [Related]
7. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
Utermann G
Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
[No Abstract] [Full Text] [Related]
9. Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
Brümmer D; Evans D; Berg D; Greten H; Beisiegel U; Mann WA
J Mol Med (Berl); 1998 Apr; 76(5):355-64. PubMed ID: 9587070
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
[TBL] [Abstract][Full Text] [Related]
11. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
[TBL] [Abstract][Full Text] [Related]
12. [Severe type III hyperlipoproteinemia with unusual lipoprotein phenotype in an adolescent patient].
Ziemer A; Göring HD
Hautarzt; 1993 Aug; 44(8):538-44. PubMed ID: 8376110
[TBL] [Abstract][Full Text] [Related]
13. New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.
Yamamura T; Yamamoto A; Sumiyoshi T; Hiramori K; Nishioeda Y; Nambu S
J Clin Invest; 1984 Oct; 74(4):1229-37. PubMed ID: 6480826
[TBL] [Abstract][Full Text] [Related]
14. [From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].
Smelt AH
Ned Tijdschr Geneeskd; 2003 Jan; 147(4):157-9. PubMed ID: 12635547
[TBL] [Abstract][Full Text] [Related]
15. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
[TBL] [Abstract][Full Text] [Related]
16. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
Hagve TA; Furuset T; Christophersen B; Ose L
Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
[TBL] [Abstract][Full Text] [Related]
17. Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia.
Hazzard WR; Warnick GR; Utermann G; Albers JJ
Metabolism; 1981 Jan; 30(1):79-88. PubMed ID: 7464557
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatment.
Janus ED; Grant S; Lintott CJ; Wardell MR
Atherosclerosis; 1985 Nov; 57(2-3):249-66. PubMed ID: 3866582
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein lipase mutation S447X associated with pancreatic calcification and steatorrhea in hyperlipidemic pancreatitis.
Chang YT; Chang MC; Su TC; Liang PC; Su YN; Kuo CH; Wei SC; Wong JM
J Clin Gastroenterol; 2009 Jul; 43(6):591-6. PubMed ID: 19034041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
